Allergy Immunotherapy Market

Allergy Immunotherapy Market: Novel Developments in SCIT to Witness a Proliferated Adoption Rate and Remain a Massive Growth Propeller: Global Industry Analysis (2015-2016) and Opportunity Assessment (2017-2025)

  • 2019-03-11
  • REP-GB-9043
  • 24 Tables
  • 90 Figures
  • 191 pages
  • Format: PDF/PPT/Excel

An Incisive, In-depth Analysis on the Allergy Immunotherapy Market

This study offers a comprehensive, 360 degree analysis on the Allergy Immunotherapy market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Allergy Immunotherapy market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

There is a sheer rise in the pervasiveness of allergies and conventional allergy treatment interventions, such as pharmacotherapy, has been often found inadequate. As a result, allergy immunotherapy, also known as hypo-sensitization or desensitization, is gaining popularity for curing several types of allergies by increasing immunological tolerance and changing the course of the disease. Personalized immunotherapy offers a long-term cure, which even lasts post the treatment of allergies, thereby, enhancing the quality of life for allergic patients.

The global allergy immunotherapy market is growing at an impressive pace, which can be attributed to the increasing consciousness of patients pertaining to the allergy treatment, rising number of allergic patients, and development of novel products. According to a recently published report by Future Market Insights (FMI), the global allergy immunotherapy market is anticipated to clock a notable CAGR of over 10% through 2025. The allergy immunotherapy market is expected to achieve a valuation of US$ 3.33 Bn by 2025 end.

Launch of Innovative Products in the Allergy Immunotherapy Market to Remain a Robust Growth Driver

Conventionally, allergy tablets gained popularity after the US Food and Drug Administration (FDA) permitted the utilization of Sublingual immunotherapy (SLIT) tablets to cure ragweed as well as grass pollen allergies. Such tablets are used to reduce the symptoms of allergy by increasing the tolerance of the allergen effects. However, the allergy tablets are capable to cure only a specific type of allergen and remains incompetent to prevent the development of new allergies, asthma and new products are in demand in the allergy immunotherapy market.

As a result, subcutaneous immunotherapy (SCIT) has been gaining traction in the allergy immunotherapy market, on account of its competency to modify the immune system and control the growth of allergies. In the year 2016, SCIT accounted for over 65% of the share in the global allergy immunotherapy market and is anticipated to contribute massively through the forecast period.

Rising Awareness of Allergies among the Patients is expected to be a Prominent Revenue Enabler to the Allergy Immunotherapy Market

As stated by the World Allergy Organization, a notable rise in the pervasiveness of allergies has been witnessed in the recent past. About 30% of the total world population have allergic rhinitis. As per Summary Health Statistics for the U.S. Adults, more than 8% of the adults in the U.S. suffer from sinusitis and hay fever. As a subsequence to the awareness created by these health organizations, governments of numerous countries have sanctioned budget for the research and development of allergy immunotherapy as an effective cure. This is one of the robust factors, which is expected to reflect substantially on the size of the allergy immunotherapy market.

Europe to Remain a Lucrative Region for the Expansion of the Allergy Immunotherapy Market

As compared to the allergy immunotherapy market of North America, Asia Pacific, the Middle East and Africa, and Latin America, Europe is anticipated to hold the largest market share through the forecast period. This is attributed to the rising awareness of allergies, surging budgets for R&D, convenient medical reimbursement policies, growing number of allergic patients, and efficient clinical pipeline products, which are fueling the growth of the allergy immunotherapy market.

On the contrary, the Asian Pacific allergy immunotherapy market is expected to grow at a steady rate, on account of a large number of the allergic population present in China and Japan.

Proliferated Adoption of Novel SLIT Therapies by the Manufacturers to Intensify the Growth Rate of Allergy Immunotherapy Market

The report highlights some of the leading players in the global allergy immunotherapy market include WOLW Pharma, Holister Stier, Leti, Allergopharma, Stallergenes Greer, Allergy Therapeutics, ALK-Abello A/S, HAL Allergy Group, Biomay AG, Circassia, DBV Technologies, Aimmune Therapeutics, and Merck KGaA, among others. The study on allergy immunotherapy market incorporates business strategies of the competitors to assist the stakeholders of the allergy immunotherapy market. With a view to sustaining the competition, the manufacturers of the global allergy immunotherapy market are rapidly adopting novel SLIT therapies to meet the unfulfilled demand of the consumers.

Allergy Immunotherapy Market - Introduction

A new report published by Future Market Insights (FMI) lends a holistic view of the global allergy immunotherapy market. This study provides an incisive look by analysing the restraints, opportunities, drivers, and pipeline products that could impact the growth of the allergy immunotherapy market. Market size has been analysed in the report in terms of revenue (US$ Mn). The allergy immunotherapy market has been studied by considering 2016 as the base year and the period 2017 to 2025 is the forecast period. This provides historical year-on-year growth data of the global allergy immunotherapy market.

The report analyses the existing as well as the future growth prospects of the allergy immunotherapy market. This will help the key stakeholders such as the manufacturers and distributors as well as the new entrants of the allergy immunotherapy market in devising sustainable strategies. The report commences with an executive summary to provide brief information about the market and its segmentation. Key trends and the recent development of the allergy immunotherapy market have been incorporated in this report, in order to help the stakeholders of the market.

Allergy Immunotherapy Market - Segmentation

This exclusive study assesses market attractiveness with the help of market segmentation. The allergy immunotherapy market has been bifurcated on the basis of region, distribution channel, treatment type and allergy type. Depending on the treatment type, allergy immunotherapy market has been segmented into sublingual immunotherapy & subcutaneous immunotherapy.

On the basis of the allergy type, the allergy immunotherapy market can be classified into asthma, allergic rhinitis, venom allergy, and food allergy, among others. Based on the distribution channel, the global allergy immunotherapy market has been fragmented into online pharmacies, retail pharmacies and drug stores, and hospital pharmacies.

Allergy Immunotherapy Market – Regional Analysis

Depending on the regions, the global allergy immunotherapy market can be classified into North America, the Middle East and Africa, Europe, Latin America, and Asia Pacific. The size and prediction for each of these regions have been incorporated in this report, along with their CAGRs for the forecasted period.

Significant countries in these regions that contribute to the growing size of the allergy immunotherapy market have also been assessed in this report. Qualitative analysis of the market has been carried out to provide information on the drivers, restraints, and opportunities prevailing in the global allergy immunotherapy market. The study also comprises of detailed analysis of market attractiveness for these regions.

Allergy Immunotherapy Market – Competition Analysis

Significant players operating in the allergy immunotherapy market comprise of Anergis, Biomay AG, Circassia, DBV Technologies, HAL Allergy Group, Merck KGaA, Allergy Therapeutics, ALK-Abello A/S, Aimmune Therapeutics, Stallergenes Greer, WOLW Pharma, Holister Stier, Allergopharma, and Leti, among others. The report encapsulates competitive scenario in order to help the stakeholders of the market understand the competition prevailing in the allergy immunotherapy market.

This market study includes a detailed overview of the companies, which provides valuable insights into the HQ, employee strength, and business segments. A detailed analysis of the product portfolio has been incorporated in this market study that provides details about the latest development in the allergy immunotherapy market.

The comprehensive study comprises of comprehensive SWOT analysis, which provides information on the key opportunities and challenges that could impact the growth of the global allergy immunotherapy market. In addition to this, the report incorporates strategic overview for each of the aforementioned firms, which helps understand the business strategies adopted by the market players. Financial overview of the significant companies of the allergy immunotherapy market has been included in this study, which will help the new entrants of the market understand the size and valuation of the companies.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology